Invesaro

Stocks EPD Financial statements

Financial statements

ENTERPRISE PRODUCTS PARTNERS L.P. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ENTERPRISE PRODUCTS PARTNERS L.P. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue23,02229,24236,53432,78927,20040,80758,18649,71556,21952,596
Cost of revenue15,71121,48726,79022,06616,72329,88745,83637,02342,58038,566
Gross profit7,3117,7559,74410,72310,47710,92012,35012,69213,63914,030
General and administrative160181208212220209241231244251
Operating income3,5813,9295,4096,0795,0356,1036,9076,9297,3387,266
Interest expense9839851,0971,2431,2871,2831,2441,2691,3521,401
Interest income1.33.611.613511274730
Other non-operating income-1,004-1,048-1,110-1,346-1,273-1,278-1,210-1,228-1,303-1,367
Pre-tax income2,5762,8814,2994,7333,7624,8255,6975,7016,0355,899
Income tax23.425.760.345.6-1247082446523
Net income to minority interests39.956.366.195.8
Net income2,5132,7994,1724,5913,7754,6345,4875,5295,8975,810
EBITDA5,1335,5737,2008,0287,1077,8088,6868,7899,3129,353
Shares, diluted (weighted)2,0892,1542,1872,2022,2022,2032,1992,1942,1922,188

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents63.15.13453351,0602,82076180583969
Receivables3,3304,3583,6594,8744,8036,9676,964
Inventory1,7711,6101,5222,0913,3042,6812,5543,3523,9553,884
Other current assets4683133123584113993944575661,302
Total current assets6,5286,5066,0617,8639,90913,27010,59812,24815,13313,360
Property, plant and equipment33,29335,62038,73841,60341,91342,08844,40145,80449,06251,359
Lease right-of-use assets210332346365364435437
Goodwill5,7455,7455,7455,7455,4495,4495,6085,6085,7125,712
Intangible assets3,8643,6903,6083,4493,3093,1513,9653,7704,0054,159
Other non-current assets86.71962034731,0971,1401,1841,222997690
Total assets52,19454,41856,97061,73364,10767,52668,10870,98277,16877,902
Accounts payable3988021,1031,005705632743
Deferred revenue168157
Short-term debt2,5772,8551,5001,9821,3251,4001,7441,3001,1501,625
Total current liabilities8,2519,2957,1689,1308,98811,62512,26513,13115,17712,832
Long-term debt21,12121,71424,67825,64328,54128,13526,55127,44830,74632,770
Lease liabilities0172321339341323366377
Other non-current liabilities5045787521,032687760941984950607
Total debt23,69824,56926,17827,62529,86629,53528,29528,74831,89634,395
Treasury stock0
Other comprehensive income-280-17250.971.4-165286365307236336
Minority interests439
Total liabilities and equity52,19454,41856,97061,73364,10767,52668,10870,98277,16877,902

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income2,5532,8564,2394,6873,8864,7555,6155,6575,9705,876
Depreciation and amortization1,5521,6441,7921,9492,0721,7051,7791,8601,9742,087
Stock-based compensation89.299.7106144159152157172188197
Deferred income tax6.66.121.420-1484060124546
Change in receivables-679-1,076730-1,249300-2,407108-810-1,4532,748
Change in inventory-872195121-558-1,420867131-714-598122
Cash from operations4,0674,6666,1266,5215,8918,5138,0397,5698,1158,585
Capital expenditures-2,984-3,102-4,223-4,532-3,288-2,223-1,964-3,266-4,544-5,620
Acquisitions-1,000-199-151000-3,2040-9490
Cash from investing-4,006-3,286-4,282-4,576-3,121-2,135-4,954-3,197-5,433-5,491
Debt issued62,81469,31579,58958,1736,67211,15996,14089,89953,71588,281
Debt repaid-61,673-68,460-77,957-56,717-4,407-11,492-97,395-89,447-50,546-85,771
Share buybacks00-30.8-81.1-186-214-250-188-219-300
Cash from financing322-1,728-1,505-1,945-2,022-4,571-5,844-4,258-2,164-2,687
Net change in cash383-347340-0.17481,807-2,759114518407
Free cash flow1,0831,5651,9031,9892,6036,2906,0754,3033,5712,965
Interest paid9489121,0181,0801,2011,2311,2321,2281,2551,352
Income taxes paid18.720.915.523.625180242012

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $36.65 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin25.6%Gross profit / revenue.
Operating margin13.4%Operating income / revenue.
EBITDA margin17.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin10.9%Pre-tax income / revenue.
Net margin10.8%Net income / revenue.
FCF margin5.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin15.2%Cash from operations / revenue.
Effective tax rate0.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)7.7%Net income / average total assets.
Capex / revenue9.2%Capital expenditures / revenue.
D&A / revenue3.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-6.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-3.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y14.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y2.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y6.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-1.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y1.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y7.6%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y0.4%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y2.5%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-1.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y1.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y9.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y5.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y2.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y7.8%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-17.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-21.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y2.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y1.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y4.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.93xCurrent assets / current liabilities.
Quick ratio0.01x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.01x(Cash + short-term investments) / current liabilities.
Debt / assets40.6%Total debt / total assets.
Net debt$32.98BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.29xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage5.24xOperating income / interest expense.
Working capital-$1.25BCurrent assets - current liabilities.
Goodwill and intangibles / assets11.9%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.72xRevenue / average total assets.
Fixed asset turnover1.12xRevenue / average property, plant and equipment.
Inventory turnover9.32xCost of revenue / average inventory.
Days inventory39 days365 x average inventory / cost of revenue.
FCF conversion54.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow60.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.89Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$26.76Revenue / diluted weighted shares.
FCF per share$1.58Free cash flow / diluted weighted shares.
Operating cash flow per share$4.05Cash from operations / diluted weighted shares.
Cash per share$0.11(Cash + short-term investments) / shares outstanding.
Buybacks / FCF11.7%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$79.14BShare price x shares outstanding.
Enterprise value$112.13BMarket cap + total debt - cash - short-term investments.
P/E12.6xMarket cap / net income. Only when net income is positive.
P/S1.35xMarket cap / revenue.
P/FCF22.9xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF8.93xMarket cap / cash from operations, when positive.
EV/Sales1.92xEnterprise value / revenue.
EV/EBIT14.3xEnterprise value / operating income, when both are positive.
EV/EBITDA11.2xEnterprise value / EBITDA, when both are positive.
EV/FCF32.4xEnterprise value / free cash flow, when both are positive.
FCF yield4.4%Free cash flow / market cap.
Earnings yield8.0%Net income / market cap (the inverse of P/E).
Shareholder yield0.5%(Dividends paid + share buybacks) / market cap.
What was ENTERPRISE PRODUCTS PARTNERS L.P.'s revenue in fiscal 2025?

ENTERPRISE PRODUCTS PARTNERS L.P. reported revenue of $52.60B for fiscal 2025, 6.4% lower than the year before.

Was ENTERPRISE PRODUCTS PARTNERS L.P. profitable in fiscal 2025?

Yes. Net income was $5.81B, a net margin of 11%.

How much free cash flow did ENTERPRISE PRODUCTS PARTNERS L.P. generate in fiscal 2025?

Cash from operations of $8.59B minus capital expenditures of $5.62B left free cash flow of $2.97B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ENTERPRISE PRODUCTS PARTNERS L.P.